Education
About Us
Working with TipRanks
Follow Us
CINDY TAHL Insider Profile
4 Followers
CINDY TAHL, Chief Legal and Compliance Officer at Fate Therapeutics, holds 397.67K shares in Fate Therapeutics (Ticker: FATE). Most recently, CINDY TAHL Sold 9,037 shares of Fate Therapeutics on Aug 05, 2025 for an estimated value of $9.49K.
CINDY TAHL Fate Therapeutics (FATE)Chief Legal and Compliance Officer
Fate Therapeutics (FATE)
Chief Legal and Compliance Officer
Ranked #99,445 out of 103,104 Corporate Insiders
Profitable Transactions
6 out of 10 Profitable Transactions
Average Return
-58.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Legal and Compliance Officer
Roles that CINDY TAHL holds in companies
Most Profitable Insider Trade
The most profitable trade made by CINDY TAHL
CINDY TAHL's Trading History
List of latest transactions for each holding click on a transaction to see CINDY TAHL's performance on stock
You May Also Like
CINDY TAHL insider profile FAQ
What is the percentage of profitable transactions made by CINDY TAHL?
The percentage of profitable transactions made by CINDY TAHL is 60%.
What is the average return per transaction made by CINDY TAHL?
The average return per transaction made by CINDY TAHL is -58.10%.
What stocks does CINDY TAHL hold?
CINDY TAHL holds: FATE stocks.
What was CINDY TAHL’s latest transaction?
CINDY TAHL latest transaction was an Informative Sell of $9.49K.
What was CINDY TAHL's most profitable transaction?
CINDY TAHL’s most profitable transaction was an Informative Sell of FATE stock on January 13, 2022. The return on the trade was 87.20%.
What is CINDY TAHL's role in Fate Therapeutics?
CINDY TAHL's role in Fate Therapeutics is Chief Legal and Compliance Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.